Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Request for applications: islet cell replacement in type 1 diabetes.

Scott Campbell1

  • 1American Diabetes Association, Research Programs, Alexandria, VA, USA. scampbell@diabetes.org

Cell Biochemistry and Biophysics
|August 4, 2004
PubMed
Summary

The American Diabetes Association is funding research into cell-based therapies for type 1 diabetes. Studies will explore engineering non-pancreatic cells, transforming stem cells, and using xenografts for insulin replacement.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rhabdomyolysis After COVID-19.

The Medical journal of Australia·2026
Same author

Chemotaxonomic and Molecular Insights into Phytoplankton Communities in Tropical Aquatic Ecosystems via MALDI FT-ICR Mass Spectrometry.

ACS measurement science au·2026
Same author

Transplantation and Mortality as Competing Outcomes Among Patients on Dialysis With Newly Diagnosed Cancer: A Longitudinal Cohort Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Initial Kidney Graft Function and its Association With Short- and Long-term Graft Outcomes: A Paired Kidney Analysis.

Transplantation·2026
Same author

Erratum: Association Between Donor-recipient Matchability, Access to Transplantation, and Posttransplant Outcomes: Erratum.

Transplantation direct·2025
Same author

Association Between Donor-recipient Matchability, Access to Transplantation, and Posttransplant Outcomes.

Transplantation direct·2025

Area of Science:

  • Diabetes research
  • Cellular therapies
  • Regenerative medicine

Background:

  • Type 1 diabetes is an autoimmune disease characterized by the destruction of insulin-producing beta cells.
  • Current treatments like insulin injections and pumps manage blood glucose but do not replace lost beta cell function.
  • Cell-based insulin replacement offers a potential cure by restoring endogenous insulin production.

Purpose of the Study:

  • To announce funding for innovative research in cell-based insulin replacement for type 1 diabetes.
  • To stimulate advancements in creating functional, glucose-sensitive insulin-producing cells.
  • To explore diverse strategies for achieving long-term glycemic control and beta cell restoration.

Main Methods:

  • Genetic engineering of nonpancreatic cells to become insulin-producing.

Related Experiment Videos

  • Directed differentiation of stem cells, pancreatic ductal cells, or endocrine cell lines.
  • Utilizing xenografts from nonhuman islet cells for transplantation.

    • Main Results:

    • Funding has been allocated to three key research areas focused on cell-based insulin replacement.
    • Research will investigate the feasibility and efficacy of engineered cells and xenografts.
    • Advancements are expected in developing glucose-sensitive, insulin-producing cell sources.

    Conclusions:

    • The American Diabetes Association is prioritizing research into novel cell therapies for type 1 diabetes.
    • These funded studies aim to overcome current limitations in diabetes management.
    • Successful outcomes could lead to transformative treatments for individuals with type 1 diabetes.